Unprecedented Phase 1 CML efficacy data with 64% MMR achievement by 24 weeks in a refractory patient populationEncouraging safety and ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

Two oral and seven poster presentations further support the CARVYKTI® research in multiple myeloma First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session ...

Terns Pharmaceuticals ( ($TERN) ) has shared an announcement. On November 3, 2025, Terns Pharmaceuticals announced that data from the Phase 1 ...

Developed by Ascentage Pharma, olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent Biologics ...

Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphomas showed encouraging preliminary efficacy data ...

Title: A dose-escalation and safety study of CID-103 followed by a randomized, open-label, parallel-arm multi-dose study ...

Q3 2025 Earnings Call November 3, 2025 8:30 AM ESTCompany ParticipantsJohn Kasel - President, CEO & DirectorWilliam Thalman ...

Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed digital asset treasury dedicated to acquiring and holding Solana (SOL), today ...

If you're a small business looking to promote your sales the day after Black Friday, here's how you can easily use AI tools to design all your marketing assets for little to no money.

BioInvent International AB ( ($SE:BINV) ) just unveiled an update. BioInvent International AB announced the presentation of updated Phase 2a data ...

A medspa playbook to turn attention into bookings—clear pages, local SEO, and one-screen scheduling. Start booking more clients today!